Chebotareva N V, Vinogradov A A, Gindis A A, Bobkova I N, Cao W, Lysenko L V
Sechenov First Moscow State Medical University (Sechenov University).
Lomonosov Moscow State University.
Ter Arkh. 2020 Jul 9;92(6):46-52. doi: 10.26442/00403660.2020.06.000671.
Chronic glomerulonephritis (CGN) is a disease with a steadily progressing course, which is based on inflammation with the activation of immune cells. The severity of the inflammatory reaction in the kidney tissue is determined by the balance of locally pro-inflammatory factors and protective mechanisms, which include anti-inflammatory cytokines and T-regulatory lymphocytes (Treg). The study of processes that can modulate the severity of inflammation in the kidney is of particular interest for understanding the basic patterns of CGN progression.
To determine the clinical significance of the Th17, Th1, and Treg cytokines in urine to assess the activity and progression of chronic glomerulonephritis with nephrotic syndrome (NS).
The study included 98 patients with CGN 37 women and 61 men. Patients were divided into two groups according to the degree of CGN activity. Group I consisted of 51 patients with NS. In 21 subjects, a decrease in GFR60 ml/min was revealed. Group II included 47 patients with proteinuria from 1 to 3 g/day without NS. GFR60 ml/min/1.73 m2 was observed in 26 patients. A kidney biopsy was performed in 65 patients and the hystological diagnosis was verified: 20 had mesangioproliferative GN, 16 had membranous nephropathy, 18 had focal segmental glomerulosclerosis, and 11 had membranoproliferative GN. The control group consisted of 15 healthy people. The levels of IL-6, IL-10, IL-17, tumor necrosis factor a (TNF-a) in the urine were determined using enzyme-linked immunosorbent assay. The number of FoxP3-positive cells in the inflammatory interstitial infiltrate of the cortical layer was determined in 39 patients (in a biopsy sample in a 1.5 mm2 area).
In group of patients with CGN, there was an increase in the levels of Th17, Th1, and Treg cytokines in urine TNF-a and IL-10 compared with healthy individuals. An increase in the levels of IL-6 in the urine of patients with high clinical activity of CGN (with NS and renal dysfunction) was more pronounced than in patients with NS and normal renal function. There was a decrease in the number of Treg cells in the interstitium of the kidney and a decrease in the production of anti-inflammatory IL-10 in CGN patients with NS, compared with patients without NS. The most pronounced changes in the cytokine profile were observed in patients with FSGS with an increase in pro-inflammatory cytokines and a decrease in Treg in the kidney tissue/anti-inflammatory IL-10 in the urine.
An imbalance of cytokines characterized by an increased levels of pro-inflammatory IL-17, IL-6, TNF-a, and a reduced levels of anti-inflammatory IL-10 and T-regulatory cells in the kidney tissue is noted in patients with NS, especially with FSGS. Imbalance of cytokines reflects the high activity of CGN and the risk of the progression of the disease.
慢性肾小球肾炎(CGN)是一种病程呈渐进性发展的疾病,其基于免疫细胞激活引发的炎症。肾组织中炎症反应的严重程度取决于局部促炎因子与保护机制之间的平衡,保护机制包括抗炎细胞因子和调节性T淋巴细胞(Treg)。研究能够调节肾脏炎症严重程度的过程,对于理解CGN进展的基本模式尤为重要。
确定尿液中Th17、Th1和Treg细胞因子的临床意义,以评估伴肾病综合征(NS)的慢性肾小球肾炎的活动度和进展情况。
该研究纳入98例CGN患者,其中37例女性,61例男性。根据CGN活动程度将患者分为两组。第一组包括51例NS患者。其中21例受试者肾小球滤过率(GFR)降至60 ml/min以下。第二组包括47例蛋白尿每日1至3 g且无NS的患者。26例患者的GFR≥60 ml/min/1.73 m²。65例患者进行了肾活检,组织学诊断得到证实:20例为系膜增生性肾小球肾炎,16例为膜性肾病,18例为局灶节段性肾小球硬化,11例为膜增生性肾小球肾炎。对照组由15名健康人组成。采用酶联免疫吸附测定法测定尿液中白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、白细胞介素-17(IL-17)、肿瘤坏死因子-α(TNF-α)的水平。在39例患者(在1.5 mm²区域的活检样本中)测定皮质层炎症性间质浸润中FoxP3阳性细胞的数量。
与健康个体相比,CGN患者组尿液中Th17、Th1和Treg细胞因子以及TNF-α和IL-10的水平升高。CGN临床活动度高(伴NS和肾功能不全)患者尿液中IL-6水平的升高比NS且肾功能正常的患者更为明显。与无NS的患者相比,NS的CGN患者肾间质中Treg细胞数量减少,抗炎性IL-10的产生减少。在局灶节段性肾小球硬化患者中观察到细胞因子谱变化最为明显,其肾组织中促炎细胞因子增加,Treg减少/尿液中抗炎性IL-10减少。
NS患者,尤其是局灶节段性肾小球硬化患者,肾组织中细胞因子失衡表现为促炎性IL-17、IL-6、TNF-α水平升高,抗炎性IL-10和调节性T细胞水平降低。细胞因子失衡反映了CGN的高活动度以及疾病进展的风险。